Ocular Side Effects of Cancer Chemotherapy
- 15 May 1982
- Vol. 49 (10) , 1999-2002
- https://doi.org/10.1002/1097-0142(19820515)49:10<1999::aid-cncr2820491009>3.0.co;2-b
Abstract
The ocular side effects of cancer chemotherapeutic drugs are relatively uncommon. Patients with cancer may develop ocular problems due to metastases to the eye or central nervous system, side effects of radiotherapy or chemotherapy, or totally independent eye disorders. We present a review of the reported ocular toxicities of chemotherapeutic agents to assist the oncologist caring for such patients.This publication has 30 references indexed in Scilit:
- Blurring of vision. A previously undescribed complication of cyclophosphamide therapyCancer, 1979
- Ocular Side Effects with 5‐FluorouracilAustralian and New Zealand Journal of Medicine, 1979
- Lacrimation and 5-FluorouracilAnnals of Internal Medicine, 1978
- Oculomotor Disturbances Associated with 5-Fluorouracil ChemotherapyAmerican Journal of Ophthalmology, 1977
- Cicatricial ectropion secondary to 5‐fluorouracil therapyMedical and Pediatric Oncology, 1977
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- Excessive Lacrimation From Fluorouracil TreatmentPublished by American Medical Association (AMA) ,1973
- Cataract after busulphan treatment.BMJ, 1972
- CLINICAL AND MORPHOLOGICAL SIDE‐EFFECTS OF BUSULFAN (MYLERAN) TREATMENTActa Medica Scandinavica, 1972
- Lens Changes in Chronic Granulocytic LeukemiaAmerican Journal of Ophthalmology, 1969